SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.26 CNY | +1.13% |
|
+11.13% | -4.29% |
| Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
| Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
Evolution of the average Target Price on Shenzhen Salubris Pharmaceuticals Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
1630e4bc3737.azKHkpw0x-Eqv1-jjDX2FrUrlNHukKlVcQIlRTZXtqI.KF3i1ttYg9Rk3BHm3VCGWMJnob-X5f8cOnoQLlNk7OQ6f8v36Fu3tHjyDg~e66d982984ccb27c04bcb6b1b59a4df1
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
31.26
CNY
Average target price
37
CNY
Spread / Average Target
+18.36%
High Price Target
41
CNY
Spread / Highest target
+31.16%
Low Price Target
33
CNY
Spread / Lowest Target
+5.57%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- 002294 Stock
- Consensus Shenzhen Salubris Pharmaceuticals Co., Ltd.
